Novartis Investigative Site is a clinical research site located in Toms River, New Jersey, United States 08755.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Novartis Investigative Site has participated in 10 clinical trials.
Therapeutic areas: Relapsing Remitting Multiple Sclerosis, Age-Related Macular Degeneration, Macular Degeneration.
Sponsors: Novartis Pharmaceuticals, Novartis.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Novartis Investigative Site has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novartis Investigative Site has 10 clinical trials on record. Their work covers Relapsing Remitting Multiple Sclerosis, Age-Related Macular Degeneration, Macular Degeneration.
Yes — Novartis Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.